SunVic Chemical Holdings Limited announced consolidated earnings results for the fourth quarter and full year ended December 31, 2017. For the quarter, the company reported revenue of RMB 605,531,000 against RMB 720,956,000 a year ago. Loss from operating activities was RMB 2,275,000 against RMB 2,278,000 reported last year. Loss before income tax was RMB 16,158,000 against RMB 19,343,000 reported last year. Net loss attributable to owners of the company was RMB 12,017,000 or 2.3 cents per basic and diluted share compared to RMB 79,704,000 or 15.0 cents per basic and diluted share in the same period last year. Net cash inflow from operating activities was RMB 184,560,000 against net cash used in operating activities of RMB 4,240,000 reported last year. Purchase of property, plant and equipment was RMB 38,656,000. Purchase of intangible assets was RMB 814,000. For the year, the company reported revenue of RMB 2,246,712,000 against RMB 2,133,553,000 a year ago. Profit from operating activities was RMB 64,476,000 against loss from operating activities of RMB 216,553,000 reported last year. Loss before income tax was RMB 17,142,000 against RMB 295,235,000 reported last year. Net loss attributable to owners of the company was RMB 20,896,000 or 3.8 cents per basic and diluted share compared to RMB 341,140,000 or 64.2 cents per basic and diluted share in the same period last year. Cash flows from operating activities were RMB 537,264,000 against RMB 308,880,000 reported last year. Purchase of property, plant and equipment was RMB 165,202,000 against RMB 82,770,000 reported last year. Purchase of intangible assets was RMB 929,000 against RMB 335,000 a year ago. Net asset value per ordinary share was 184.8 cents against 188.8 cents a year ago. The increase in revenue was mainly due to increase in revenue from sale of acrylic acid (AA) and acrylate esters (AE) as well as other chemical products by RMB 39.3 million and RMB 85.5 million respectively, which were partially offset by a decrease in revenue from sale of PMIDA & glyphosate by RMB 11.7 million.